{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:07:24Z","timestamp":1789495644360,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Published literatures on repeat renal biopsy of AL amyloidosis have basically reached a consensus that amyloid material deposit does not disappear or diminish after satisfactory hematologic response, regardless of renal response. However, the need of a repeat renal biopsy in such situation is still controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Here we reported a case of histologically confirmed \u03bb Type renal AL amyloidosis who had been classified as Stage I and low risk at initial diagnosis. The patient received a total of six courses of CyBorD chemotherapy. She had achieved complete hematologic remission after two courses of chemotherapy but consistently had large amount of proteinuria over 10\u00a0g\/day during follow up. A repeat renal biopsy was performed nine months after the first one and indicated mild to moderate increase of amyloid deposits as well as significant glomerulosclerosis and interstitial lesions, suggesting a lack of histological renal improvement despite her satisfactory hematologic response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case indicated renal involvement in AL amyloidosis could progress after successful hematologic treatment, and supported the value of repeat renal biopsy in the evaluation of AL amyloidosis patients lacking renal response despite of complete hematologic remission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-022-02752-4","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:03:19Z","timestamp":1648713799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Value of repeat renal biopsy in the evaluation of AL amyloidosis patients lacking renal response despite of complete hematologic remission: a case report and literature review"],"prefix":"10.1186","volume":"23","author":[{"given":"Ping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4393-6661","authenticated-orcid":false,"given":"Yunlin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"issue":"44","key":"2752_CR1","first-page":"3540","volume":"96","author":"XH Zhihong Liu","year":"2016","unstructured":"Zhihong Liu XH. Nan Chen: Guideline for diagnosis and treatment of systemic AL amyloidosis. National Medical Journal of China. 2016;96(44):3540\u20138.","journal-title":"National Medical Journal of China"},{"issue":"23","key":"2752_CR2","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood.2020006913","volume":"136","author":"G Palladini","year":"2020","unstructured":"Palladini G, Milani P, Merlini G. Management of AL amyloidosis in 2020. Blood. 2020;136(23):2620\u20137.","journal-title":"Blood"},{"issue":"9","key":"2752_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","volume":"34","author":"R Rysava","year":"2019","unstructured":"Rysava R. AL amyloidosis: advances in diagnostics and treatment. Nephrol Dial Transplant. 2019;34(9):1460\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"2752_CR4","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1038\/s41375-018-0060-x","volume":"32","author":"E Muchtar","year":"2018","unstructured":"Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, et al. Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria. Leukemia. 2018;32(10):2240\u20139.","journal-title":"Leukemia"},{"issue":"1","key":"2752_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13506129.2019.1672650","volume":"27","author":"A Angel-Korman","year":"2020","unstructured":"Angel-Korman A, Jaberi A, Sanchorawala V, Havasi A. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. Amyloid. 2020;27(1):17\u201324.","journal-title":"Amyloid"},{"issue":"3","key":"2752_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5414\/CN107162","volume":"79","author":"H Okuyama","year":"2013","unstructured":"Okuyama H, Yamaya H, Fukusima T, Yokoyama H. A patient with persistent renal AL amyloid deposition after clinical remission by HDM\/SCT therapy. Clin Nephrol. 2013;79(3):233\u20136.","journal-title":"Clin Nephrol"},{"issue":"5","key":"2752_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s10157-009-0198-y","volume":"13","author":"O Yamazaki","year":"2009","unstructured":"Yamazaki O, Ubara Y, Suwabe T, Nakanishi S, Hoshino J, Sawa N, Hayami N, Yamanouchi M, Takemoto F, Kenmei T, et al. Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation. Clin Exp Nephrol. 2009;13(5):522\u20135.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"2752_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5414\/CNP63215","volume":"63","author":"M Nakayama","year":"2005","unstructured":"Nakayama M, Kashiwagi M, Katafuchi R, Hori K, Hayashi S, Fujimi S. Resolution of primary amyloidosis by melphalan and prednisolone: a case report. Clin Nephrol. 2005;63(3):215\u201320.","journal-title":"Clin Nephrol"},{"issue":"8","key":"2752_CR9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archinte.1982.00340210037009","volume":"142","author":"RA Kyle","year":"1982","unstructured":"Kyle RA, Wagoner RD, Holley KE. Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone. Arch Intern Med. 1982;142(8):1445\u20137.","journal-title":"Arch Intern Med"},{"issue":"7","key":"2752_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/ndt\/gfv018","volume":"30","author":"S Safadi","year":"2015","unstructured":"Safadi S, Saad A, Quint PS, Sethi S, Leung N, Kurtin P, Nasr SH. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis. Nephrol Dial Transplant. 2015;30(7):1151\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2752_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jama.2020.5493","volume":"324","author":"MA Gertz","year":"2020","unstructured":"Gertz MA, Dispenzieri A. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review. JAMA. 2020;324(1):79\u201389.","journal-title":"JAMA"},{"issue":"5","key":"2752_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","volume":"63","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis. 2014;63(5):820\u201334.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2752_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45\u201359.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"2752_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, Laumann K, Zeldenrust SR, Leung N, Dingli D, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012;30(9):989\u201395.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2752_CR15","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/ajh.25940","volume":"95","author":"E Muchtar","year":"2020","unstructured":"Muchtar E, Gertz MA, Lacy MQ, Leung N, Buadi FK, Dingli D, Hayman SR, Go RS, Kapoor P, Gonsalves W, et al. Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio. Am J Hematol. 2020;95(11):1280\u20137.","journal-title":"Am J Hematol"},{"issue":"3","key":"2752_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/13506129.2017.1360272","volume":"24","author":"S Rubinstein","year":"2017","unstructured":"Rubinstein S, Cornell RF, Du L, Concepcion B, Goodman S, Harrell S, Horst S, Lenihan D, Slosky D, Fogo A, et al. Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis. Amyloid. 2017;24(3):205\u201311.","journal-title":"Amyloid"},{"issue":"9","key":"2752_CR17","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.5858\/arpa.2012-0159-CR","volume":"137","author":"RM Roth","year":"2013","unstructured":"Roth RM, Benson D, Hebert LA, Bissell MG, Satoskar AA, Nadasdy T, Brodsky SV. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis. Arch Pathol Lab Med. 2013;137(9):1304\u20138.","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"2752_CR18","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/ndt\/gfg436","volume":"18","author":"M Zeier","year":"2003","unstructured":"Zeier M, Perz J, Linke RP, Donini U, Waldherr R, Andrassy K, Ho AD, Goldschmidt H. No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement. Nephrol Dial Transplant. 2003;18(12):2644\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2752_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s13730-019-00416-1","volume":"9","author":"N Toriu","year":"2020","unstructured":"Toriu N, Sawa N, Hiramatsu R, Mizuno H, Ikuma D, Sekine A, Hayami N, Sumida K, Yamanouchi M, Hasegawa E, et al. Regression of renal amyloid deposits by VAD therapy plus autologous stem cell transplantation in a patient with primary AL amyloidosis. CEN Case Rep. 2020;9(1):6\u201310.","journal-title":"CEN Case Rep"},{"issue":"36","key":"2752_CR20","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","volume":"30","author":"G Palladini","year":"2012","unstructured":"Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, Schonland S, Hegenbart U, Comenzo R, Kastritis E, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol. 2012;30(36):4541\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2752_CR21","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1053\/ajkd.2000.16205","volume":"36","author":"GR Hetzel","year":"2000","unstructured":"Hetzel GR, Uhlig K, Mondry A, Helmchen U, Grabensee B. AL-amyloidosis of the kidney initially presenting as minimal change glomerulonephritis. Am J Kidney Dis. 2000;36(3):630\u20135.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2752_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/oxfordjournals.ndt.a027413","volume":"11","author":"PB Fernando","year":"1996","unstructured":"Fernando PB, Faria MS, Capucho R, Costa E, Guerra L, Faria V. Faria V: Non-Hodgkin lymphoma and glomerulonephritis. What kind of relation. Nephrol Dial Transplant. 1996;11(5):854\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2752_CR23","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/ndt\/12.7.1520","volume":"12","author":"L Harper","year":"1997","unstructured":"Harper L, Adu D. Glomerulonephritis and non-Hodgkin lymphoma. Nephrol Dial Transplant. 1997;12(7):1520\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2752_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3143\/geriatrics.58.453","volume":"58","author":"S Fukunaga","year":"2021","unstructured":"Fukunaga S, Hoshino Y, Ooba M, Kawanishi M, Yoshikane K, Egawa M, Ito T, Tanabe K. Investigation of the safety and usefulness of a renal biopsy for older elderly patients >\/=75 years old. Nihon Ronen Igakkai Zasshi. 2021;58(3):453\u20138.","journal-title":"Nihon Ronen Igakkai Zasshi"},{"issue":"4","key":"2752_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/healthcare9040474","volume":"9","author":"K Torigoe","year":"2021","unstructured":"Torigoe K, Muta K, Tsuji K, Yamashita A, Abe S, Ota Y, Mukae H, Nishino T. Safety of Renal Biopsy by Physicians with Short Nephrology Experience. Healthcare (Basel). 2021;9(4):474.","journal-title":"Healthcare (Basel)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02752-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:09:48Z","timestamp":1648714188000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02752-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2752"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02752-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"24 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethic committee of Sichuan Provincial People\u2019s Hospital (No 2017.124). Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent to participate this study from the patient is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A copy of the written consent to publish this study from the patient is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report there are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}